IL6 and COVID-19: This trend is consistent with the findings of Li et al (Li et al., 2024), who reported similar elevations in CRP, PCT, and IL-6 in pediatric M. pneumoniae infections in Guangzhou following the COVID-19 pandemic, with these markers correlating with infection severity.